Novel Genetic Mouse Model of Early-Onset Glaucoma
Principal Investigator
Saidas Nair, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
July 01, 2019 - June 30, 2021
Grant ID
G2019360
Goals
Blinding diseases affecting children and young adults are mainly caused by defective genes, which are typically passed on from parent to their children. Our mission is to identify the culprit gene and find out how they act to cause blindness. The completion of this project will help us move forwards towards finding solutions to control and manage the disease.
Summary
We have characterized a mouse model of glaucoma that recapitulates features of early-onset glaucoma in humans. Mouse studies provide an important extension to human studies that allows detailed mechanistic understanding. Findings from the proposed studies will lead to a better understanding of the molecular mechanisms contributing to elevated intraocular pressure, a major risk factor for glaucoma. Importantly, it has potential to provide us with a robust new genetic mouse model to study glaucomatous neurodegeneration, which is much needed to advance glaucoma research. Uncovering the molecular basis of a disease is key to development of therapeutic intervention(s) to prevent/slow down glaucoma progression.
Related Grants
National Glaucoma Research
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute